Amgen Drug with Immunotherapy Extends Lung Cancer Survival
Amgen's drug, Imdelltra, approved for adults with advanced small cell lung cancer worsening after chemotherapy, has shown to reduce the risk of death by 40% when combined with immunotherapy. This combination therapy extends survival in lung cancer patients, according to recent trial data.
Hindu Health·




